-
Johnson & Johnson and AbbVie Earn a New FDA Approval for Imbruvica
Post on 4/23/20
-
Quest Diagnostics to Double U.S. Coronavirus Testing Capacity by Mid-May
Post on 4/23/20
-
The Role of Telemedicine in Chronic Disease — During and After COVID-19
Post on 4/22/20
-
LuckyVitamin Supports Frontline Healthcare Workers by Offering FREE LV+ Memberships During the COVID-19 Pandemic
Post on 4/22/20
-
Coronavirus Relief Survey: 84% of Americans Want Another Stimulus Check – WalletHub
Post on 4/22/20
-
Rite Aid Chooses Opko Health Unit for Drive-Up Coronavirus Testing Services
Post on 4/22/20
-
Cyclacel Prices $20M Public Offering
Post on 4/21/20
-
Mental Health Technologies Offers Free Online Anxiety and Depression Screening Service to the Public During COVID-19 Crisis
Post on 4/21/20
-
Provention Bio: The First Type 1 Diabetes Breakthrough In A 100 Years
Post on 4/21/20
-
Novartis to Test Hydroxychloroquine as Possible Coronavirus Treatment
Post on 4/21/20
-
Vela Diagnostics Receives BARDA Funding
Post on 4/20/20
-
Novolex Repurposes to Manufacture Medical Protective Equipment
Post on 4/20/20
-
Rite Aid Expands COVID-19 On-Site Testing with Seven New Locations Across Four States
Post on 4/19/20
-
electroCore Provides Business Update
Post on 4/19/20
-
Tabula Rasa HealthCare and CQuentia Expand Partnership
Post on 4/19/20
-
Why J&J Stock Is Up
Post on 4/17/20
-
Inovio Pharmaceuticals Lands $6.9 Million Grant to Fund a Clinical Trial for Its Coronavirus Vaccine
Post on 4/17/20
-
Why Rite Aid's Q4 Earnings Caused the Stock to Tank More Than 20%
Post on 4/17/20
-
Is Inovio Pharmaceuticals a Ticking Time Bomb For Investors?
Post on 4/17/20
-
LuckyVitamin Supports Frontline Healthcare Workers by Offering FREE LV+ Memberships During the COVID-19 Pandemic
Post on 4/15/20
-
GHR Named Healthcare Staffing Agency for Philadelphia Field Hospital
Post on 4/15/20
-
2020’s Best & Worst States for Children’s Health Care – WalletHub Study
Post on 4/15/20
-
Better Coronavirus Stock: Moderna vs. Pfizer
Post on 4/15/20
-
Coronavirus Impacts Lead Johnson & Johnson to Slash Its 2020 Expectations
Post on 4/15/20
-
Dow Jones News: Johnson & Johnson Cuts Outlook; JPMorgan Chase Prepares for the Worst
Post on 4/15/20
Philadelphia
